-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Tango Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q2 2024.
- Tango Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $65K, a 1.56% increase year-over-year.
- Tango Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $175K, a 52.2% increase year-over-year.
- Tango Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $134K, a 148% increase from 2022.
- Tango Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $54K, a 81.5% decline from 2021.
- Tango Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $292K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)